Skip to content

Freenome

US · FRNM #2882 by market cap Listed 2024
9.36 -0.57 -5.69%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 9.80 -1.26%
After-hours 9.37 +0.11%
Overnight 9.86 -0.65%
17.119.369.362026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on FRNM?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -21.8% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 4.3% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 02:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall C

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 93.6% Better than 98%
Operating margin -734.9% Better than 3%
Net margin -721.3% Better than 3%
Momentum C-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -32.2% Better than 16%
6-month return -16.2% Better than 31%
12-month return (ex latest month) 18.8% Better than 57%
Distance below 52-week high 46.5% Better than 22%
Financial Health D+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 5.6x Better than 88%
Debt to assets 61.5% Better than 8%
Interest coverage -76.8x Better than 6%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 92.3% Better than 82%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -10.09%
1M -33.43%
3M -30.72%
6M -16.35%
YTD -28.17%
1Y -12.93%

Key statistics

Price & volume

Prev close
9.93
Open
9.82
Day range
9.28 - 9.84
Avg price
9.45
Volume
621.76K
Turnover
5.88M
Amplitude
5.64%
52-week range
9.28 - 17.50

Valuation

P/E
-3.92
P/E (TTM)
-3.92
P/B
2.17
EPS
-2.39
Net profit
-266.49M
Net assets
481.35M

Share structure

Market cap
1.04B
Float cap
465.98M
Shares out
111.50M
Float shares
49.78M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2024-06-12
52-week range 1% of range
9.28 17.50

46.5% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-5.32M net over the window

Short interest

Shares short
4.63M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Freenome (FRNM)?

Freenome last traded at 9.36. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Freenome's market cap?

About 1.04B.

What is the P/E ratio of Freenome?

The trailing twelve-month P/E is -3.92. The Valuation tab shows it against the stock's own five-year range.

Does Freenome pay a dividend?

Freenome does not currently pay a regular dividend.

Is Freenome a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 18.00, which implies 92.3% upside from the current price. This is not investment advice.

What is Freenome's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Freenome a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Freenome discussion 0 comments

Add a comment